covid-19

As COVID-19 cases rise some cases are returning after usage of Pfizer’s antiviral pill, putting the efficacy of the medication into question. The drug was first authorized in December 2021 for adults with preconditions based on a study where 1,000 adults took the pill. Since then the United States…

The White House has issued a warning that COVID-19 could infect 100 million people in the fall and winter similar to surges at this time of year in 2021 and 2020. This estimation is based on the assumption no new variants arise and COVID-19 funding and precautions remain the same as what they are…

Scientists are developing a way to block the first site of contact of the virus: the nose. There are currently eight nasal vaccines that are under development with three of them in phase 3 trials. But, producing these vaccines have been very slow because of the distinct formulas they require. These…

A new study has shown some severe COVID-19 cases to cause substantial damage to cognitive processes. Researchers from the University of Cambridge found 400,000 people who may have a level of cognitive impairment equivalent to a 10-point IQ drop or the mental decline that occurs between ages 50 and…

Although the United States has seen a recent spike in COVID-19 cases, there doesn’t seem to be a rise in severe illness. Areas where Omicron sub-variants such as BA.2 first hit have seen a flattening in cases. In other places such as New York, easier spreading omicron versions such as BA.2.12.1…

As a fourth shot rolls around, many people are curious if getting vaccinated (and keeping up with it) will help reduce the chances of getting long Covid, should they become infected. So far, studies in the United Kingdom suggest that those who are vaccinated are less likely to experience long Covid…

After only being licensed for use in adults, Moderna petitioned the FDA on Thursday to obtain emergency use authorization for the shot in young children up to the age of five. Pfizer and BioNTech had earlier requested the FDA to approve their vaccine for young children in February, only for the FDA…

According to recent data from the US Centers for Disease Control and Prevention, about 60% of adults and 75% of children have antibodies suggesting COVID-19 infection. At the start of December, a projected 34% of Americans had antibodies indicating that they had previously been infected with the…

Recent research suggests that the COVID-19 vaccination may heighten the risk of heart inflammation, which can be deadly. However, according to a meta-analysis presented in The Lancet Respiratory Medicine, the rate of cardiac inflammation after receiving a COVID-19 vaccination was equivalent to that…

In March, the Food and Drug Administration authorized a second booster for people ages 50 and up. Shortly after, the CDC approved the FDA's move, saying that these individuals "may" take a second booster if they choose, but that they should speak with their doctors to determine if the second…

A new study from the Health Institute Carlos III in Madrid, Spain has linked shorter telomere length to higher COVID-19 mortality, particularly in older women. Telomeres are the end tips of a chromosome and they are made of repetitive sequences of non-coding DNA that protect the chromosome…

The Biden Administration is looking to push for COVID-19 funding as soon as Congress returns from recess. Before the recess, the White House had a $10 billion bipartisan deal stalled in the senate. Half of the $10 billion will go towards therapeutics with the rest being designated for vaccines and…

With the mask mandate being lifted for public transportation, there are more and more people referring to COVID-19 as an “ordinary seasonal virus”. Despite a significant decrease in the number of COVID-19 cases over the past couple of months, more than 35, 000 people in the US are infected daily.…

The new more transmissible sub-variant, BA.2 currently accounts for approximately three-quarters of U.S cases. Not only that. But BA.2 seems to have given rise to its own sub-lineage, BA.2.12.1, which is likely to be contributing to the rise in case numbers in some states. The differences in…